TYTakahito Yagi

Takahito Yagi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Takahito Yagi has a total of 117 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Subclinical Pulmonary Hypertension is a Strong Risk of Post Living Donor Liver Transplantation Survival for Liver Cirrhosis

    by Yosuke Saragai, Akinobu Takaki, Yuzo Umeda, Tetsuya Yasunaka, Ryuji Kaku, Kazufumi Nakamura, Takahito Yagi, Susumu Shinoura, Ryuichi Yoshida, Daisuke Nobuoka, et al.

  • A sofosbuvir-based direct-acting antiviral treatment regimen exhibits a strong protective effect against post-liver transplantation chronic hepatitis C recurrence

    by Atsushi Oyama, Akinobu Takaki, Tetsuya Yasunaka, Takuya Adachi, Fusao Ikeda, Nozomu Wada, Yasuhito Takeuchi, Hideki Onishi, Shinichiro Nakamura, Hidenori Shiraha, et al.

    肝移植後C型肝炎に対するDirect Acting Antivirals(DAA)治療効果を検討した.Genotype1は29症例で,ダクラタスビル+アスナプレビル(DCV+ASV)5例,ソホスブビル+レジパスビル(SOF+LDV)25例(含DCV+ASV無効1例),Genotype2が2症例でSOF+リバビリン治療を行った.DCV+ASVは5例中4例で治療完遂,3例でSustained viral response(SVR)24を達成.SOF+LDVは全例SVR24を達成.移植後2カ月以内の肝炎再燃例も含まれているが問題なく治療完遂可能であった.Genotype2はSVR24を達成.SOF中心レジメンで100%のSVR24達成率であり,移植後早期においても問題なくウイルス駆除達成可能であった.C型肝硬変の肝移植適応評価においてC型肝炎のネガティブインパクトはなくなったと言っても過言ではない.

  • Pancreatic Hepatoid Carcinoma Mimicking a Solid Pseudopapillary Neoplasm: A Challenging Case on Endoscopic Ultrasound-guided Fine-needle Aspiration

    by Yutaka Akimoto, Hironari Kato, Kazuyuki Matsumoto, Ryo Harada, Shinsuke Oda, Soichiro Fushimi, Shou Mizukawa, Shuntaro Yabe, Daisuke Uchida, Hiroyuki Seki, et al.

    A 59-year-old man was admitted to our hospital for treatment of a 45 mm pancreatic mass found during a medical examination. Endoscopic ultrasound-guided fine-needle aspiration cytology showed polygonal cells with pseudopapillary structures. The tumor cells were positive for nuclear/cytoplasmic β-catenin and CD10, and negative for chromogranin A. After a tentative diagnosis of a solid pseudopapillary neoplasm, middle pancreatectomy was performed. Histologically, polygonal cells with abundant eosinophilic cytoplasm formed in the trabeculae and were immunohistochemically positive for HepPar1 and protein induced by vitamin K absence or antagonist-II. The tumor was finally diagnosed to be pancreatic hepatoid carcinoma. No recurrence occurred for 12 months, even without adjuvant chemotherapy.


    • 29 April 2015
      • Vol. 62  (138) , 441-6

    Correlation of computed tomography imaging features and pathological features of 41 patients with pancreatic neuroendocrine tumors.

    by Masashi Utsumi, Yuzo Umeda, Kosei Takagi, Kuise Takashi, Daisuke Nobuoka, Ryuichi Yoshida, Susumu Shinoura, Hiroshi Sadamori, Takahito Yagi, Toshiyoshi Fujiwara

    Pancreatic neuroendocrine tumors (PNET) are relatively rare. Here, we present clinical and pathological characteristics of PNETs to show a relationship between computed tomography (CT) imaging and the 2010 World Health Organization (WHO) classification. We retrospectively reviewed the records of 41 PNET patients who were treated between 2002 and 2012. All tumors were classified as neuroendocrine tumor (NET) grade 1 (G1), NET grade 2 (G2), or neuroendocrine carcinoma (NEC) grade 3 (G3) on the basis of the 2010 WHO classification system. Twenty-five tumors were classified as G1, 11 as G2, and five as G3. Mean sizes of the G1, G2 and G3 tumors were 1.84 ± 0.54, 4.90 ± 0.84, and 5.62 ± 1.18 cm, respectively, (P < 0.01). A PNET is typically hypervascular and exhibits contrast enhancement on enhanced CT. Higher percentage of G1 tumors demonstrated typical imaging and showed a significantly greater distinct mass compared with G2 and G3 tumors. Although PNET has many imaging features that appear on CT, G2 and G3 tumors often show atypical imaging features, particularly with large sizes and/or ill-defined features, when compared with G1 tumors. If a PNET has atypical imaging features, possibility of malignancy should be considered.


    • 24 February 2015
      • Vol. 61  (136) , 2167-72

    Risk factors of morbidity and predictors of long-term survival after hepatopancreatoduodenectomy for biliary cancer.

    by Masashi Utsumi, Hiroshi Sadamori, Susumu Shinoura, Yuzo Umeda, Ryuichi Yoshida, Daisuke Nobuoka, Kosei Takagi, Toshiyoshi Fujiwara, Takahito Yagi

    Hepatopancreatoduodenectomy (HPD) is performed to achieve radical resection of malignant biliary tumors. We reviewed clinical outcomes to evaluate the utility of HPD in terms of morbidity and mortality. A retrospective analysis was conducted on 17 patients underwent HPD between August 1991 and May 2013; 9 bile duct cancer, 5 advanced gallbladder and 3 pancreatic tumor with liver metastasis. The morbidity and mortality rates were 88.3% and 0%, respectively. Univariate analysis showed that a body mass index of ≥22 and preoperative total bilirubin level ≥0.8 mg/dl were significantly associated with severe complications. One-, 3- and 5-year survival rate were 73.3%, 60.0% and 30.0%. In 14 patients with biliary carcinoma, univariate analysis showed that a histological grade of G1 was significantly associated with survival. Patients without pancreatic invasion or portal vein invasion tended to survive longer than patients with these types of invasion, although the difference was not significant. HPD can be performed with no mortality and provides a survival benefit for some patients with biliary carcinoma undergoing curative resection. In patients with grade G1 biliary carcinoma without pancreatic or portal vein invasion in particular, this aggressive surgery might offer a chance of long-term survival.


  • Transplanted liver graft ischemia caused by pediatric ERCP in the prone position

    by Koichiro Tsutsumi, Hironari Kato, Hiroyuki Okada, Takahito Yagi, Kazuhide Yamamoto

    Endoscopic retrograde cholangiopancreatography (ERCP) for biliary complications after liver transplant is safe and useful in children and adults [1] [2] [3]. Here, we report a very rare case of a child in whom liver graft ischemia developed after therapeutic post-transplant ERCP. A 5-year-old boy, who had received a living donor liver transplant with a reduced left lateral segment graft [4] for Alagille syndrome at 1 year of age, was admitted for cholangitis. Magnetic resonance imaging revealed a bilioenteric anastomotic stricture and hepatolithiasis. ERCP with a short double-balloon enteroscope (EI-530B; Fujifilm, Tokyo, Japan) was performed while the patient was under general anesthesia and in the standard prone position. After the anastomosis had been reached, balloon dilation, stone removal, and the placement of three plastic stents were completed without complications within 2 hours ([Fig. 1]). However, 2 hours after ERCP, abdominal pain and acutely elevated liver enzymes (aspartate aminotransferase, 5433 IU/L; alanine aminotransferase, 2161 IU/L; lactate dehydrogenase, 2018 IU/L) occurred. Computed tomography revealed a lesion with delayed enhancement and a nonenhanced geographic lesion in the liver graft; the lesions had the appearance of a cylinder whose center axis passed through the top, ventral part of the graft, irrespective of the hepatic segment ([Fig. 2]), suggestive of hepatic ischemia with partial infarction. Fortunately, the liver dysfunction decreased with infusion therapy ([Fig. 3]), so that another transplant was avoided. However, 3 months later, the patient’s liver volume had slightly decreased ([Fig. 4]). Hepatic ischemia has been described after prolonged surgery in the prone position [5] but not after ERCP, to the best of our knowledge. In this case, the distribution of a lesion with delayed enhancement on computed tomography suggested that this hemodynamic change had been induced by prolonged, excessive pressure on the liver graft, which protruded ventrally, when it was compressed between the spine and operating table while the patient was in the prone position. Therefore, it is important to note the size and location of a liver graft before a post-transplant patient undergoes ERCP. Endoscopy_UCTN_Code_CPL_1AK_2AC


    • 1 November 2013
      • Vol. 40  (12) , 1959-61

    [A case of advanced sigmoid colon cancer successfully treated with multimodality therapy].

    by Naoki Nishie, Ryo Inada, Yoshiko Mori, Yoshitaka Kondo, Futoshi Uno, Takeshi Nagasaka, Masashi Utsumi, Yuzo Umeda, Hiroshi Sadamori, Takahito Yagi, et al.

    A 61-year-old man underwent sigmoidectomy with partial cystectomy for advanced sigmoid colon cancer with unresectable multiple liver metastases at the Okayama University Hospital in June 2006. Pathological examination revealed moderately differentiated adenocarcinoma, pStage IV( pSI[ bladder], pN0, pH2, pP0, pM0), as per the Japanese Classification of Colorectal Carcinoma, seventh edition. The patient underwent systematic chemotherapy with irinotecan, 5-fluorouraci( l 5-FU), and folinic acid( FOLFIRI) and oxaliplatin, Leucovorin, and 5-FU( mFOLFOX6) for 13 months. In July 2007, hepatectomy was performed as the liver metastatic lesions had shrunk to a resectable size. Follow-up computed tomography (CT) in November 2009 revealed recurrence in the liver and lung. Subsequently, lateral segmentectomy was performed for the recurrent liver lesions, and radiofrequency ablation( RFA) was performed for the lung lesions. After having undergone RFA, the patient is doing well without any re-recurrence. We encountered a patient with advanced sigmoid colon cancer who was successfully treated with multimodality therapy. For patients with advanced or recurrent colorectal cancers, curative resection can lead to a good prognosis; however, in most patients, it is difficult to achieve curative resection by upfront surgery. Multimodality therapy could facilitate curative resection, thereby resulting in a good prognosis.

  • Open Access

    Serial Changes of Serum Growth Factor Levels and Liver Regeneration after Partial Hepatectomy in Healthy Humans

    by Kazuyuki Matsumoto, Yasuhiro Miyake, Yuzo Umeda, Hiroshi Matsushita, Hiroaki Matsuda, Akinobu Takaki, Hiroshi Sadamori, Kazuhiro Nouso, Takahito Yagi, Toshiyoshi Fujiwara, et al.

    This study aimed to investigate the associations of the serial changes of serum levels of various growth factors with liver regeneration after hepatectomy in healthy liver donors. Sixteen healthy liver donors who underwent conventional liver resection were included. Serum levels of various growth factors before hepatectomy and on postoperative day (POD) 1, 3, 5 and 7 were measured. Liver volume data calculated by multi-detector computed tomography using workstation. The ratio of remnant liver volume on POD 0 to liver volume before the operation was 51% ± 20%. The ratio of liver volume on POD 14 to liver volume on POD 0 were inversely correlated with remnant liver volume on POD 0 (r = −0.91). The ratio of liver volume on POD 14 to liver volume on POD 0 were significantly correlated with serum hepatocyte growth factor (HGF) levels on POD 1 (r = 0.54), serum leptin levels on POD 1 (r = 0.54), and serum macrophage colony-stimulating factor (M-CSF) levels on POD 5 (r = 0.76) and POD 7 (r = 0.80). These results suggest that early-phase elevation of serum levels of HGF, leptin and M-CSF may be associated with the acceleration of liver regeneration after hepatectomy in humans.


    • 1 October 2013
      • Vol. 110  (10) , 1823-30

    [Two cases of lymphoepithelial cyst of the pancreas confirmed by contrast-enhanced endoscopic ultrasound].

    by Kazuyuki Matsumoto, Hironari Kato, Takeshi Tomoda, Ichiro Sakakihara, Yasuhiro Noma, Naoki Yamamoto, Takayuki Sonoyama, Koichiro Tsutsumi, Hiroshi Sadamori, Hiroyuki Okada, et al.

    We report our experience with two cases of lymphoepithelial cysts (LECs) of the pancreas. Both patients were in their sixties. Contrast-enhanced computed tomography revealed masses in the pancreas with multilocular cystic lesions. Endoscopic ultrasound (EUS) findings presented highly echo-dense structures in the cystic masses; however, contrast-enhanced EUS revealed only the septum inside each mass without enhancing the dense structures. Contrast-enhanced EUS was useful for defining the contents in the cystic lesions; therefore, it may be useful for the diagnosis of LEC.


  • Living donor liver transplantation to a survivor of liver resection for hepatocellular carcinoma with major portal vein invasion.

    by Hiroshi Sadamori, Takahito Yagi, Susumu Shinoura, Yuzo Umeda, Ryuichi Yoshida, Daisuke Sato, Daisuke Nobuoka, Masashi Utsumi, Toshiyoshi Fujiwara

    We present a case of living donor liver transplantation to a 3-year disease-free survivor of liver resection for hepatocellular carcinoma (HCC) with major portal vein invasion. A 48-year-old man had HCC in the right lobe with a portal venous tumor thrombus extending into the left portal vein. An extended right lobectomy with thrombectomy was performed to remove the thrombus. Three years after liver resection, the patient experienced liver failure, with massive ascites and jaundice due to the formation of a thrombus in the main and left portal veins. During the 3 years after liver resection, no metastasis or recurrence of HCC had been detected, and tumor markers had been within normal ranges. The portal venous thrombus did not show any arterial enhancement under contrast-enhanced computed tomography, suggesting that the co-existence of any HCC component in the portal venous thrombus may have been negative. Based on these findings, living donor liver transplantation was performed using a right lobe graft from the patient's son. The patient is alive at 87 months after the transplantation, with no evidence of HCC recurrence.